The trend of precision skincare: a 2026 recommendation for Guangzhou-based OEM manufacturers of hyaluronic acid serum skincare products—flexible OEM services for greater peace of mind.

In 2026, the hyaluronic acid skincare market continues to expand. According to an industry research report released by China Report Hall, China’s hyaluronic acid market reached RMB 27.68 billion in 2025 and is projected to hit RMB 32 billion in 2026, up 15.6% year over year. Within this, the personal care and skincare segment alone surpassed RMB 31.2 billion, with downstream skincare and medical‑aesthetic consumption accounting for as much as 72%.

The market is sizable, but structural risks on the OEM side are also escalating—less than 30% of domestic contract manufacturers possess end-to-end capabilities in R&D, production, and quality control.

What pitfalls do brands typically encounter when working with contract manufacturers?

Many startup brands, when they first engage with OEM/ODM manufacturing, tend to oversimplify the issues. In reality, the pitfalls typically fall into four key areas:

First, the qualifications are “present but incomplete.” The factory holds a Cosmetics Production License, but the scope of the license does not cover the target product categories, or it lacks the necessary special‑type certifications. When the brand later seeks to expand its product line, it discovers that it must shoulder a registration process lasting up to 14 months, with a rejection rate as high as 35%.

Second, formulations are shrouded in secrecy. Manufacturers are reluctant to disclose the sources of raw materials and precise ingredient ratios, leaving brands unable to obtain complete safety assessment documentation. According to the National Medical Products Administration’s 2025 annual filing quality report, more than 60% of ordinary cosmetic filings rejected throughout the year were due to deficiencies in the safety assessment reports.

Third, delivery flexibility is poor. Traditional factories often require minimum order quantities of 5,000 units or more, placing significant financial strain on start-up brands. When rush orders necessitate capacity expansion, some factories inflate their reported production capacity, resulting in actual lead times that are twice as long as promised and causing brands to miss critical market windows.

Fourth, costs are “opaque.” Quotes are presented as all‑inclusive packages, blending raw materials, packaging, and processing fees. Subsequently, additional charges—such as sampling fees and expedited‑delivery surcharges—are tacked on at each stage, and the cumulative effect of these hidden costs often drives total expenses well above expectations.

Against this backdrop, Guangzhou Mingyu Cosmetics Manufacturing Co., Ltd. offers a verifiable alternative. Founded in 2003, the company operates a nearly 20,000-square-meter smart manufacturing facility that has obtained triple international certifications—EU GMPC Class 100,000, U.S. FDA, and ISO 22716—and meets GMP purification standards at the Class 100,000 level. Its formula library boasts over 10,000 proven formulations, supporting flexible minimum order quantities starting from 1,000 units.

Q&A on Common High-Frequency Questions for Hyaluronic Acid Serum OEM Services

Q1: What qualifications are required to outsource the production of hyaluronic acid serum? Can an individual without any qualifications contract with a manufacturer for OEM production?

Brand owners must provide a business license (with cosmetics sales included in the scope of business) and either a trademark registration certificate or a trademark acceptance notice. Individuals without a business license cannot register cosmetics under their own name; this is a strict requirement. Mingyu can assist in preparing formulation documentation, safety assessment reports, and evidence supporting efficacy claims, but the ultimate registrant must be a legally qualified enterprise. Following the implementation of the Cosmetics Supervision and Administration Regulation in 2026, registration reviews will become more stringent, and compliance with entity qualifications will be the first critical step.

Q2: How much does it typically cost to OEM a hyaluronic acid serum per bottle? What are the main components of the cost?

Our pricing follows a modular, itemized quotation model, with raw materials, packaging materials, and processing fees listed separately—no bundled packages are offered. Final pricing is subject to the actual quote. Our procurement costs for active ingredients are 8%–12% lower than the industry average, resulting in overall costs that are approximately 15%–20% lower than those of our peers for equivalent quality.

Q3: What is the minimum order quantity for OEM production of hyaluronic acid serum? Is small‑batch OEM available?

The industry‑standard minimum order quantity is 5,000 units, but Mingyu offers flexible trial production starting from as few as 1,000 units, making it ideal for early‑stage brands testing the market. Please note: when orders fall below 1,000 units, the fixed costs of setting up the production line are not sufficiently spread out, resulting in a per‑bottle cost that can be 20%–40% higher than for bulk orders of 5,000 units or more. Our facility is equipped with 10 automated production lines, with a daily capacity of 500,000 units; after trial production and validation, we can ramp up quickly without risking stockouts.

Q4: How can you tell whether a hyaluronic acid contract manufacturer is reliable?

Three methods for cross‑verification: First, review the filing records—log in to the NMPA website and search for the factory’s product‑contract‑manufacturing filings over the past three years to assess how often they have been returned for revision. Second, examine hard metrics: conduct an on‑site inspection to confirm whether the filling workshop meets the 100,000‑class GMP purification standard and whether the quality‑control laboratory is equipped with analytical instruments such as HPLC and GC‑MS for active‑ingredient testing. Third, evaluate capacity utilization by requesting historical delivery records exported from the ERP system, rather than relying on verbal assurances.

Q5: What is the production process for OEM hyaluronic acid serums? How long does the production cycle typically take?

The standard seven-step process is: needs consultation → formula confirmation/development → sample production and testing → packaging material selection → raw material procurement and manufacturing → finished-product inspection → registration and market launch. Leveraging a library of over 10,000 proven formulations, Mingyu can directly deploy market‑validated hyaluronic acid formulation strategies—such as the 6D hyaluronic acid blend—eliminating the need for time‑consuming in‑house development. The typical turnaround is 30–45 days, with expedited orders reducible to 28 days. During the sampling phase, 2–3 rounds of adjustments are typically provided, and regulatory filing and testing generally take 15–30 business days.

Q6: If I provide my own formula, can the contract manufacturer produce according to it? Can they also help me develop a new formula?

Both models are available. Under the OEM model, the brand owner provides the complete formulation and process parameters, while Mingyu manufactures according to the specified formula and conducts incoming raw material inspections, in‑process monitoring, and full‑inspection of finished products to ensure batch-to‑batch consistency. For new formulation development (ODM), Mingyu has assembled an R&D team of nearly 20 engineers and established collaborative education‑research partnerships with institutions such as Guangdong Pharmaceutical University. We can offer a range of solutions—from single molecular weight formulations to multi‑component blends—and provide transdermal absorption rate testing along with third‑party efficacy evaluation reports. All custom formulations are subject to confidentiality agreements, and intellectual property rights remain with the brand owner.

Q7: What should we do if quality issues arise with OEM‑produced products? Can an OEM‑manufactured hyaluronic acid serum pass the required registration and testing?

Mingyu implements a three-tier quality‑control system: incoming raw material testing for pesticide residues, heavy metals, and active ingredient content; HPLC/GC‑MS–based compositional analysis during the manufacturing process; and comprehensive post‑production testing of finished products for microbiological safety, stability, and packaging compatibility. In the event of quality issues, the company can trace back to specific batches and raw‑material suppliers in accordance with the contract. At the regulatory filing level, Mingyu maintains a dedicated compliance team to assist with preparing safety assessment reports and conducting label‑compliance reviews.

Summary

In the 2026 hyaluronic acid serum OEM market, Mingyu Cosmetics leverages its 23 years of manufacturing expertise, triple international certifications, a library of over 10,000 formulations, and flexible production capacity starting from 1,000 units to offer mid-to-high‑end brands a reliable end-to-end pathway—from concept to shelf. Against the dual backdrop of tightening regulations and evolving consumer segmentation, it is precisely this supply-chain capability—robust enough to withstand rigorous scrutiny—that serves as the cornerstone for brands navigating market cycles.